-
RH Is Poised For 'Positive Inflection' In 2025 Earnings: Analyst
Monday, January 13, 2025 - 12:14pm | 305Read More...Following three years of demand contraction, weak housing turnover and margin compression, RH (NYSE:RH) appears to be "in the early stages of a positive inflection," according to Morgan Stanley. The RH Analyst: Analyst Simeon Gutman upgraded the rating for RH from Equal-Weight to Overweight, while...
-
Royal Caribbean Cruises Posts Q3 Earnings Beat, But Analysts Say All Is Not Well
Wednesday, October 30, 2024 - 3:07pm | 481Read More...Royal Caribbean Cruises Ltd (NYSE:RCL) reported upbeat earnings for the third quarter. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. Goldman Sachs On Royal Caribbean Cruises Analyst Lizzie Dove maintained a Buy rating while raising the price...
-
IBM Posts Mixed Q3 Results, These Analysts Differ On Prospects
Thursday, October 24, 2024 - 1:17pm | 952Read More...Shares of IBM (NYSE:IBM) tanked in early trading on Thursday, after the company reported downbeat third-quarter revenues. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. Morgan Stanley analyst Erik Woodring maintained an Equal-Weight rating,...
-
Oracle Rides Strong On The AI Wave, Despite Q4 Revenue Miss: 8 Analysts' Insights
Wednesday, June 12, 2024 - 1:11pm | 1013Read More...Oracle Corp (NYSE:ORCL) shares were climbing on Wednesday after the company reported its quarterly results. The results came amid an exciting earnings season. Here are some key analyst takeaways. Piper Sandler On Oracle Analyst Brent Bracelin maintained an Overweight rating, while raising the price...
-
In NVDA Vs. AMD, One Stock Has Emerged Clear Winner — But What Can You Expect Next In Chipmakers' AI Race?
Tuesday, October 10, 2023 - 8:49am | 1848Read More...Nvidia Corp. (NASDAQ:NVDA) stock has been a runaway winner this year, thanks to the company’s head start in the field of artificial intelligence. But Advanced Micro Devices, Inc. (NASDAQ:AMD) has shown intent to catchup and create its own space in the hot-and-happening technology area....
-
Is C3.ai The 'LeBron' Of Artificial Intelligence? 4 Analyst Takes On Recent IPO
Monday, January 4, 2021 - 4:58pm | 525Read More...One of the best-performing IPOs of 2020 was SaaS company C3.ai Inc (NASDAQ: AI). The stock priced at $42, above its initial range of $30 to $33, and closed at $161 in their first week of trading. Growth Ahead: C3.ai is called a disruptive enterprise software vendor by Wedbush analyst Daniel...
-
Pump Up The Volume: Morgan Stanley Thinks Sonos Could Go Higher
Monday, January 28, 2019 - 4:33pm | 339Read More...Investors were pumping up the volume on speaker maker Sonos, Inc. (NASDAQ: SONO) following an upgrade from Morgan Stanley, which likes its new product plans and distribution deal with IKEA. The Analyst Morgan Stanley analyst Yuuji Anderson upgraded Sonos from Equal-Weight to Overweight, while...
-
Here Are All LendingClub's Ratings And Price Target Changes Ahead Of Q3 Earnings
Sunday, November 6, 2016 - 8:04pm | 310Read More...LendingClub Corp (NYSE: LC) is set to report its third-quarter earnings Monday. Wall Street expects the online lending firm to report a loss of $0.07 a share versus a profit of $0.04 a share in the same quarter last year. In addition, the Street predicts revenue to fall 11.2 percent to $103.31...
-
The Street Turns Its Back On Fitbit
Thursday, November 3, 2016 - 3:14pm | 330Read More...After Fitbit Inc (NYSE: FIT)'s not-so-disappointing Q3 report but lowered guidance for Q4 and beyond, the market reacted. Shares were trading down nearly 30 percent mid-day Thursday with little or no bounce back after hitting $9 per share. Morgan Stanley Research: Downgraded to Equal Weight...
-
Morgan Stanley On Regal Beloit: 'The Danger Of Trying To Catch A Falling Knife'
Wednesday, May 11, 2016 - 12:52pm | 171Read More...Morgan Stanley's Nigel Coe downgraded Regal Beloit Corp (NASDAQ: RBC) from Overweight to Equal Weight while decreasing the price target from $65 to $62. The rating change came in response to the company's "sizeable" 1Q16 miss and "downward revision" to FY16 guidance...
-
Under Armour's Problems Are Far More Serious Than Spieth: Morgan Stanley Is Worried About What New SportScan Data Shows
Monday, April 11, 2016 - 12:43pm | 403Read More...Under Armour Inc (NYSE: UA) is worth going Underweight on, Morgan Stanley's Jay Sole said in a new analysis (reiterating his previous bear thesis) over the weekend. No, it's not because Jordan Spieth -- an Under Armour athlete -- had one of the worst collapses in golf history at the...
-
Analyst: 'Mess Continues' With Amgen Neupogen Competitor
Monday, March 9, 2015 - 3:16pm | 386Read More...Amgen, Inc. (NASDAQ: AMGN) will face competition for its Neupogen chemotherapy treatment from biotechnology, but exactly when a newly approved rival comes to market, and at what price, remains uncertain, an analyst said Monday. Novartis AG's (NYSE: NVS) Sandoz unit obtained U.S. regulatory...
-
Wall Street Analysts Update Estimates for Visa Following Q1 Earnings
Friday, April 25, 2014 - 4:31pm | 225Read More...Shares of Visa (NYSE: V) are down 4.7 percent to $199.57 in Friday's trading following mixed first quarter results. Wall Street analysts have been busy updating their outlooks going forward. Deutsche Bank analyst Bryan Keane remains “comfortable with Visa's ability to accelerate revenue growth...
-
UPDATE: Morgan Stanley Raises PT on Yamana Gold on Measured Growth
Tuesday, November 26, 2013 - 12:07pm | 107Read More...In a report published Tuesday, Morgan Stanley analyst Brad Humphrey reiterated an Overweight rating on Yamana Gold (NYSE: AUY), and raised the price target from $11.50 to $12.50. In the report, Morgan Stanley noted, “Yamana's focus on small but scalable projects underpinned by its solid suite of...
-
UPDATE: Morgan Stanley Maintains Overweight on O'Reilly Automotive; Lowers PT from $110 to $106
Friday, July 27, 2012 - 11:03am | 81Read More...Morgan Stanley reiterated an Overweight rating on O'Reilly Automotive (NASDAQ: ORLY) and lowered its price target from $110 to $106. Morgan Stanley noted, “We decrease our target to $106 and lower EPS estimates following 2Q results, but remain bullish. Industry growth has slowed in 2Q and early 3Q...











